Finance

Lists
1AFX:BIT
Carl Zeiss Meditec AG
31,20 €
+0,45%
(+0,14) 1D
2 հոկ, 17:26:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1AFX...
Open
31,20 €
High
31,20 €
Low
31,20 €
Mkt. cap
2,95 մլրդ
Avg. vol.
39,00
Volume
15,00
Dividend
1,76%
Quarterly dividend
0,14 €
Ex-dividend date
27 մրտ, 2026 թ.
P/E ratio
22,71
52-wk high
48,30 €
52-wk low
22,88 €
EPS
1,37 €
No. of employees
6 հզր
Open
31,20 €
High
31,20 €
Low
31,20 €
Mkt. cap
2,95 մլրդ
Avg. vol.
39,00
Volume
15,00
Dividend
1,76%
Quarterly dividend
0,14 €
Ex-dividend date
27 մրտ, 2026 թ.
P/E ratio
22,71
52-wk high
48,30 €
52-wk low
22,88 €
EPS
1,37 €
No. of employees
6 հզր
News stories
From web sources and news partners
Profile
Carl Zeiss Meditec AG is a multinational medical technology company. Headquartered in Jena, Germany, the company operates as part of the larger Carl Zeiss Group. Doing business as ZEISS Medical Technology, the company develops and manufactures solutions for ophthalmology, dentistry, oncology, neurosurgery, microsurgery, and other medical applications. Wikipedia
About Carl Zeiss Meditec AG
CEOMarkus Weber
Employees5,8 հզր
Founded2002
HeadquartersԵնա, Թյուրինգիա, Գերմանիա
Sector-
Websitezeiss.com
Last report
06 օգս, 2026 թ.
Fiscal period
Q3 2026
0,54 € / 0,40 €
+35,00%beat
Revenue / Est. (EUR)
562,72 մլն / 540,72 մլն
+4,07%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
627,54 մլն
467,00 մլն
524,00 մլն
562,72 մլն
Cost of goods sold
295,75 մլն
239,80 մլն
260,62 մլն
260,44 մլն
Cost of revenue
295,75 մլն
239,80 մլն
260,62 մլն
260,44 մլն
Research and development expenses
91,78 մլն
75,50 մլն
89,30 մլն
78,94 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
169,64 մլն
152,00 մլն
150,59 մլն
162,39 մլն
Operating expense
261,40 մլն
227,50 մլն
237,90 մլն
240,02 մլն
Total operating expenses
557,15 մլն
467,30 մլն
498,52 մլն
500,46 մլն
Operating income
70,40 մլն
-300,00 հզր
25,48 մլն
62,26 մլն
Other non operating income
-4,02 մլն
-200,00 հզր
4,27 մլն
7,88 մլն
EBT including unusual items
67,29 մլն
-5,50 մլն
25,79 մլն
69,16 մլն
EBT excluding unusual items
62,61 մլն
-5,50 մլն
25,79 մլն
69,16 մլն
Income tax expense
13,05 մլն
200,00 հզր
6,76 մլն
16,40 մլն
Effective tax rate
19,39%
-3,64%
26,21%
23,71%
Other operating expenses
-17,00 հզր
-
-1,99 մլն
-1,31 մլն
Net income
51,81 մլն
-4,90 մլն
19,57 մլն
55,03 մլն
Net profit margin
8,26%
-1,05%
3,73%
9,78%
Earnings per share
-
0,03
0,45
0,54
Interest and investment income
570,00 հզր
1,20 մլն
1,28 մլն
2,09 մլն
Interest expense
-6,30 մլն
-6,00 մլն
-6,16 մլն
-5,93 մլն
Net interest expenses
-5,73 մլն
-4,80 մլն
-4,88 մլն
-3,84 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
83,01 մլն
12,31 մլն
63,70 մլն
74,87 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps